Table 1.

Hepatitis C Screening Recommendations issued by the United States Preventive Services Task Force (USPSTF), Centers for Disease Control and Prevention (CDC), and the American Association for the Study of Liver Disease and the Infectious Disease Society of America (AASLD-IDSA)

Risk factor	USPSTF	CDC	AASLD- IDSA
Adults born during 1945–1965	X	X	X
Current or past injection drug use	X	X	X
Receipt of blood transfusion before 1992	X	X	X
Receipt of clotting factor concentrates produced before 1987		X	X
Organ transplant before July 1992		X	X
Long-term hemodialysis	X	X	X
Children born to HCV-positive women	X	X	X
Incarceration	X		X
Intranasal drug use	X	*	X
Other non-injecting illegal drug use		*
Receipt of an unregulated tattoo	X	*	X
Other percutaneous exposures	X
Healthcare, emergency medical, and public safety workers after needle sticks, sharps, or mucosal exposures to HCV-positive blood		X	X
HIV-infected		X	X
Persistently abnormal alanine aminotransferase (ALT)		X	X
Unexplained chronic liver disease and chronic hepatitis			X
Solid organ donors (deceased and living)			X
Persons with a history of multiple sex partners or sexually transmitted diseases		*
Long-term steady sex partners of HCV-positive persons		*
Recipients of transplanted tissue (e.g. corneal, musculoskeletal, skin, ova, sperm)		*

Adapted from Guidelines and Guidance from United States Preventive Services Task Force (USPSTF), Centers for Disease Control and Prevention (CDC), and the American Association for the Study of Liver Disease and the Infectious Disease Society of America (AASLD-IDSA)

Abbreviations: Hepatitis C Virus (HCV); United States Preventive Services Task Force (USPSTF); Centers for Disease Control and Prevention (CDC), and the American Association for the Study of Liver Disease and the Infectious Disease Society of America (AASLD-IDSA); Alanine aminotransferase (ALT)

^*Mentioned in guidelines but described as of uncertain need